sorafenib has been researched along with cblc137 in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (cblc137) | Trials (cblc137) | Recent Studies (post-2010) (cblc137) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 39 | 0 | 39 |
| Protein | Taxonomy | sorafenib (IC50) | cblc137 (IC50) |
|---|---|---|---|
| DNA (cytosine-5)-methyltransferase 3A | Mus musculus (house mouse) | 7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Cheng, CL; Chin, DW; Law, CT; Lee, D; Lee, JM; Ng, IO; Shen, J; Tsang, FH; Wei, L; Wong, CC; Wong, CM | 1 |
1 other study(ies) available for sorafenib and cblc137
| Article | Year |
|---|---|
Histone chaperone FACT complex mediates oxidative stress response to promote liver cancer progression.
Topics: Animals; Antineoplastic Agents; Carbazoles; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Gene Knockout Techniques; High Mobility Group Proteins; Histone Chaperones; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Mice, Inbred BALB C; Mice, Nude; Oxidative Stress; Sorafenib; Transcription Factors; Transcriptional Elongation Factors; Up-Regulation; Xenograft Model Antitumor Assays | 2020 |